Literature DB >> 15110034

Limbic-frontal circuitry in major depression: a path modeling metanalysis.

D A Seminowicz1, H S Mayberg, A R McIntosh, K Goldapple, S Kennedy, Z Segal, S Rafi-Tari.   

Abstract

This paper reports the results of an across lab metanalysis of effective connectivity in major depression (MDD). Using FDG PET data and Structural Equation Modeling, a formal depression model was created to explicitly test current theories of limbic-cortical dysfunction in MDD and to characterize at the path level potential sources of baseline variability reported in this patient population. A 7-region model consisting of lateral prefrontal cortex (latF9), anterior thalamus (aTh), anterior cingulate (Cg24), subgenual cingulate (Cg25), orbital frontal cortex (OF11), hippocampus (Hc), and medial frontal cortex (mF10) was tested in scans of 119 depressed patients and 42 healthy control subjects acquired during three separate studies at two different institutions. A single model, based on previous theory and supported by anatomical connectivity literature, was stable for the three groups of depressed patients. Within the context of this model, path differences among groups as a function of treatment response characteristics were also identified. First, limbic-cortical connections (latF9-Cg25-OF11-Hc) differentiated drug treatment responders from nonresponders. Second, nonresponders showed additional abnormalities in limbic-subcortical pathways (aTh-Cg24-Cg25-OF11-Hc). Lastly, more limited limbic-cortical (Hc-latF9) and cortical-cortical (OF11-mF10) path differences differentiated responders to cognitive behavioral therapy (CBT) from responders to pharmacotherapy. We conclude that the creation of such models is a first step toward full characterization of the depression phenotype at the neural systems level, with implications for the future development of brain-based algorithms to determine optimal treatment selection for individual patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110034     DOI: 10.1016/j.neuroimage.2004.01.015

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  232 in total

1.  Corticostriatal-limbic gray matter morphology in adolescents with self-reported exposure to childhood maltreatment.

Authors:  Erin E Edmiston; Fei Wang; Carolyn M Mazure; Joanne Guiney; Rajita Sinha; Linda C Mayes; Hilary P Blumberg
Journal:  Arch Pediatr Adolesc Med       Date:  2011-12

Review 2.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

Review 3.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

4.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

5.  Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons.

Authors:  Daniel J Urban; Hu Zhu; Catherine A Marcinkiewcz; Michael Michaelides; Hidehiro Oshibuchi; Darren Rhea; Dipendra K Aryal; Martilias S Farrell; Emily Lowery-Gionta; Reid H J Olsen; William C Wetsel; Thomas L Kash; Yasmin L Hurd; Laurence H Tecott; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2015-09-18       Impact factor: 7.853

6.  The cognitive-emotional brain: Opportunities [corrected] and challenges for understanding neuropsychiatric disorders.

Authors:  Alexander J Shackman; Andrew S Fox; David A Seminowicz
Journal:  Behav Brain Sci       Date:  2015       Impact factor: 12.579

7.  EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression.

Authors:  Maher A Quraan; Andrea B Protzner; Zafiris J Daskalakis; Peter Giacobbe; Chris W Tang; Sidney H Kennedy; Andres M Lozano; Mary P McAndrews
Journal:  Neuropsychopharmacology       Date:  2013-11-28       Impact factor: 7.853

8.  Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression.

Authors:  Amit Anand; Yu Li; Yang Wang; Mark J Lowe; Mario Dzemidzic
Journal:  Psychiatry Res       Date:  2009-02-20       Impact factor: 3.222

9.  A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder.

Authors:  Yiheng Tu; Jiliang Fang; Jin Cao; Zengjian Wang; Joel Park; Kristen Jorgenson; Courtney Lang; Jun Liu; Guolei Zhang; Yanping Zhao; Bing Zhu; Peijing Rong; Jian Kong
Journal:  Brain Stimul       Date:  2018-01-31       Impact factor: 8.955

10.  Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing.

Authors:  Shinpei Yoshimura; Yasumasa Okamoto; Keiichi Onoda; Miki Matsunaga; Go Okada; Yoshihiko Kunisato; Atsuo Yoshino; Kazutaka Ueda; Shin-ichi Suzuki; Shigeto Yamawaki
Journal:  Soc Cogn Affect Neurosci       Date:  2013-01-17       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.